|Bid||5.180 x 0|
|Ask||5.210 x 0|
|Day's Range||5.100 - 5.290|
|52 Week Range||5.040 - 9.330|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||10.50|
HONG KONG, July 5, 2018 /PRNewswire/ -- Sisram Medical Ltd ("Sisram" or "the Company") (Hong Kong: 1696) an investment holding company specializing in medical technology for healthcare, has laid out its vision to become a global MedTech leader, leveraging its solid funding channels, strong R&D capabilities and comprehensive portfolio of products. Sisram has solid financial backing as a member of the Fosun family of companies, a leading investment group with China roots that is gaining a global foothold. Sisram became a publicly-traded company in September 2017, as the first Israeli company to be listed on the Hong Kong Stock Exchange Main Board, under stock code 1696.HK.
"FDA clearance of our innovative Trio applicator once again solidifies Alma's position as the technology and market leader in the global aesthetic market. Soprano is the most recognized brand in the world and we once again have changed the paradigm in aesthetic medicine.
Adjusted Net Profit Increased by 30.6% to US$13.3 Million HONG KONG , Sept. 29, 2017 /PRNewswire/ -- Sisram Medical Ltd ("Sisram Med" or the "Company"; stock code: 1696.HK), a leading ...
HONG KONG , Sept. 20, 2017 /PRNewswire/ -- The leading global provider of energy-based medical aesthetic treatment systems - Sisram Medical Ltd ( "Sisram Med" or the "Company" ; stock ...
The valid applications received pursuant to the Hong Kong public offering represented approximately 17.58 times of the total number of 11,000,000 Hong Kong offer shares initially available for subscription. Due to the over-subscription, a total number of 22,000,000 shares have been reallocated from the international offering to the Hong Kong public offering.
Industry: Medical Devices
Full Time Employees: 381
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical and minimally invasive treatment systems worldwide. It offers a portfolio of treatment systems for non-invasive medical aesthetic treatments, including hair removal, skin rejuvenation, skin resurfacing, vascular and pigmented lesions treatment, tattoo removal, acne treatment, cellulite reduction, body contouring, and skin tightening; and minimally invasive treatments, such as vaginal rejuvenation, laser-based liposuction, treatment of varicose veins, and ear, nose and throat procedures. The company sells its products directly to treatment providers, such as plastic surgeons and dermatologists, primary care physicians, obstetricians, gynecologists, and aestheticians, as well as ear, nose, and throat specialists; and to distributors. Sisram Medical Ltd offers its products under the Alma, Soprano, Harmony, Accent, and FemiLift brands. The company was incorporated in 2013 and is headquartered in Caesarea, Israel.